TAOX — TAO Synergies Inc.

Clinical-stage biopharmaceutical company developing a bryostatin‑1 platform for Alzheimer’s and other neurodegenerative/cognitive diseases. Also pivoting to a digital-asset treasury strategy focused on acquiring and staking TAO cryptocurrency.

Company profile

• Sector: Healthcare
• Industry: Biotechnology
• Country: US
• Exchange: NASDAQ
• Employees: 4
• Website: https://www.synaptogen.com

Latest SEC filings for TAOX

• S-3/A — 2026-10-23
• S-3/A — 2026-10-09
• 10-Q — 2026-08-13
• 10-K/A — 2026-06-05
• 10-Q — 2026-05-13
• 10-K — 2026-03-31
• S-3/A — 2026-01-02
• 8-K — 2025-12-19

Abrir análisis completo

Educational tool only — not investment advice.